Overview. Verzenios is a cancer medicine used to treat women with breast cancer that is advanced or has spread to other parts of the body (metastatic).
People also ask
Is Verzenio a chemotherapy drug?
How much longer do you live with Verzenio?
How bad are Verzenio side effects?
Is Verzenio the same as tamoxifen?
Verzenio is a prescription medicine to treat adults with HR+, HER2– breast cancer that has spread to other parts of the body (metastasized).
Apr 8, 2024 · Abemaciclib is a type of cancer growth blocker that targets the proteins cyclin dependant kinase 4 and 6 (CDK4 and CDK6) on breast cancer cells.
Abemaciclib is used to treat breast cancer that is oestrogen receptor positive (ER-positive) and HER2-negative. It can be taken by both men and women.
Aug 6, 2024 · Verzenio treats all stages of hormone-receptor-positive, HER2-negative breast cancer by stopping cancer cells from dividing and growing.
Abemaciclib
Medication
Abemaciclib, sold under the brand name Verzenio among others, is a medication for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6. Wikipedia
AHFS/Drugs.com: Monograph
ATC code: L01EF03 (WHO)
Bioavailability: 45%
Elimination half-life: 18.3 hrs
License data: US DailyMed: Abemaciclib
Other names: LY2835219
Pronunciation: /əˌbɛməˈsaɪklɪb/; ə-BEM-ə-SY-klib
Show more
Show less
INDICATIONS AND USAGE --------------------------. VERZENIO® is a kinase inhibitor indicated: • in combination with endocrine therapy (tamoxifen or an ...
Feb 28, 2019 · Abemaciclib inhibits cell division in the cancer cells, slowing down tumor growth. Go to: Application. Abemaciclib is available in the ...
Verzenio is an oral medication for certain people with HR+, HER2- metastatic breast cancer (MBC).
Verzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal ...
Verzenios is indicated for the treatment of women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally ...
